undamentalytics Newsletter
Sign in

Medicinova Inc revenue

Medicinova Inc's revenue was $409,657 in fiscal 2025, down 59.0% on the year before. Since fiscal 2012 ($802,580) it has grown at a compound -20.1% a year. Over the last twelve months it was $920,481.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2012Dec 20122021Dec 20212023Dec 20232025Dec 2025LTMJun 2026
Revenue8034,0381,000410920
Growth on the year before—+403.1%−75.2%−59.0%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Biotechnology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Medicinova Inc $920,481 875.7% —
Shattuck Labs, Inc. $1.0m -66.6% 5.2%
Longeveron Inc. $1.2m -42.7% 10.4%
Dare Bioscience, Inc. $1.4m 4366.5% —
Cartesian Therapeutics, Inc. $1.5m 44.0% -68.8%
Absci Corp $1.6m -62.3% -43.3%

Compare with peers

Head to head: MNOV vs STTKLGVN vs MNOVDARE vs MNOV

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Medicinova Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Medicinova Inc.